Barchart.com
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Corbus Pharmaceuticals Hldgs Inc (CRBP)

Corbus Pharmaceuticals Hldgs Inc (CRBP)
5.01 x 2 5.05 x 1
Post-market by (Cboe BZX)
5.02 +0.10 (+2.03%) 04/04/25 [NASDAQ]
5.01 x 2 5.05 x 1
Post-market 5.02 unch (unch) 16:00 ET
News & Headlines for Fri, Apr 4th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity GlobeNewswire - Fri Mar 28, 7:00AM CDT

CRBP : 5.02 (+2.03%)
Corbus Pharmaceuticals: Q4 Earnings Snapshot AP - Tue Mar 11, 7:17AM CDT

Corbus Pharmaceuticals: Q4 Earnings Snapshot

CRBP : 5.02 (+2.03%)
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update GlobeNewswire - Tue Mar 11, 7:00AM CDT

CRBP : 5.02 (+2.03%)
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Feb 25, 7:00AM CST

CRBP : 5.02 (+2.03%)
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 GlobeNewswire - Fri Feb 14, 6:30AM CST

CRBP : 5.02 (+2.03%)
Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU GlobeNewswire - Tue Feb 11, 6:30AM CST

CRBP : 5.02 (+2.03%)
Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference GlobeNewswire - Tue Jan 28, 7:00AM CST

CRBP : 5.02 (+2.03%)
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025 GlobeNewswire - Wed Jan 8, 7:00AM CST

CRBP : 5.02 (+2.03%)
Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Mon Jan 6, 7:00AM CST

CRBP : 5.02 (+2.03%)
Corbus Pharmaceuticals Advances Oncology Research with First Patient Dosed in CRB-601 Clinical Trial for Advanced Solid Tumors Quiver Quantitative, Inc. - Mon Dec 9, 2024

Corbus Pharmaceuticals begins Phase 1 trial for CRB-601, a monoclonal antibody targeting advanced solid tumors.Quiver AI SummaryCorbus Pharmaceuticals Holdings, Inc. recently announced the dosing of the...

CRBP : 5.02 (+2.03%)

Barchart Exclusives

How Trump Just Liberated a Massive Discount in Unsung AI Hero Pure Storage (PSTG) Barchart - 31 minutes ago
Although ‘Liberation Day’ has been chaotic for the tech ecosystem, the core fundamentals arguably remain incredibly attractive for PSTG stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades
Wed, Apr 09, 2025 5:00 PM UTC
Reserve Your Spot